Literature DB >> 11528157

Guillain-Barré syndrome in Spain, 1985-1997: epidemiological and public health views.

J I Cuadrado1, J de Pedro-Cuesta, J R Ara, C A Cemillán, M Díaz, J Duarte, M D Fernández, O Fernández, F García-López, A García-Merino, R García-Montero, J A Martínez-Matos, F Palomo, J Pardo, A Tobías.   

Abstract

Retrospective demographic information and hospital record data were collected for 337 patients resident in Spain who had validated Guillain-Barré syndrome (GBS) diagnoses and clinical onset during the period 1985-1997 and had been admitted to 11 centres, covering a population of 3.9 million. The European age-adjusted GBS incidence per 100,000 for 1985-1997 among the population aged 20 and over was 0.85, with a breakdown of 1.14 in men and 0.58 in women. Incidence increased with age and time, with occasional rises that mimicked outbreaks and occurred at irregular 2- to 4-year intervals, mainly in winter. Spatial variation was modest. Respiratory and gastrointestinal infections respectively constituted 49.3 and 19.3% of recorded preceding events. The 97.5% intercentile limit, obtained from the 1985-1997 monthly incidences using predictions from a Poisson model, was proposed as the threshold value for pilot epidemiological surveillance of GBS in 1998-1999. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11528157     DOI: 10.1159/000050769

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  8 in total

Review 1.  Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis.

Authors:  James J Sejvar; Andrew L Baughman; Matthew Wise; Oliver W Morgan
Journal:  Neuroepidemiology       Date:  2011-03-21       Impact factor: 3.282

2.  Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study.

Authors:  Pei Zheng; De-Cai Tian; Yuwen Xiu; Yongjun Wang; Fu-Dong Shi
Journal:  Lancet Reg Health West Pac       Date:  2021-11-02

3.  Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review.

Authors:  Yitao Zhang; Yanyin Zhao; Yi Wang
Journal:  Chin Neurosurg J       Date:  2018-06-18

4.  Guillain-Barré syndrome: clinical profile and management.

Authors:  Sreenivasa Rao Sudulagunta; Mahesh Babu Sodalagunta; Mona Sepehrar; Hadi Khorram; Shiva Kumar Bangalore Raja; Shyamala Kothandapani; Zahra Noroozpour; Mohammed Aheta Sham; Nagendra Prasad; Sony Parethu Sunny; Munawar Dhanish Mohammed; Rekha Gangadharappa; Ranjitha Nidsale Sudarshan
Journal:  Ger Med Sci       Date:  2015-09-21

5.  Incidence, Disability, and Mortality in Patients With Guillain-Barré Syndrome in Korea: A Nationwide Population-Based Study.

Authors:  Sang-Wook Yi; Jung Hwan Lee; Ji-Man Hong; Young-Chul Choi; Hyung Jun Park
Journal:  J Clin Neurol       Date:  2022-01       Impact factor: 3.077

6.  Guillain-Barré syndrome: natural history and prognostic factors: a retrospective review of 106 cases.

Authors:  Inés González-Suárez; Irene Sanz-Gallego; Francisco Javier Rodríguez de Rivera; Javier Arpa
Journal:  BMC Neurol       Date:  2013-07-22       Impact factor: 2.474

7.  Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.

Authors:  Enrique Alcalde-Cabero; Javier Almazán-Isla; Fernando J García López; José Ramón Ara-Callizo; Fuencisla Avellanal; Carlos Casasnovas; Carlos Cemillán; José Ignacio Cuadrado; Jacinto Duarte; María Dolores Fernández-Pérez; Óscar Fernández; Juan Antonio García Merino; Rosa García Montero; Dolores Montero; Julio Pardo; Francisco Javier Rodríguez-Rivera; María Ruiz-Tovar; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

8.  A Bayesian Network to Predict the Risk of Post Influenza Vaccination Guillain-Barré Syndrome: Development and Validation Study.

Authors:  Yun Huang; Chongliang Luo; Ying Jiang; Jingcheng Du; Cui Tao; Yong Chen; Yuantao Hao
Journal:  JMIR Public Health Surveill       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.